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Background: We have recently shown that mice with experimental autoimmune encephalomyelitis (EAE) have
increased sleep fragmentation (SF) and reduced sleep efficiency, and that the extent of SF correlates with the
severity of disease. It is not yet clear whether and how sleep promotes recovery from autoimmune attacks. We
hypothesized that SF promotes leukocyte infiltration across the blood-spinal cord barrier, impairs immune
regulation, and thus worsens EAE.
Methods: Three groups of C57 mice were studied: Resting EAE; SF EAE with the mice subjected to the SF
maneuver 12 h /day during zeitgeber time (ZT) 0–12 h; and naïve controls with neither EAE nor SF. Besides
monitoring of the incidence and severity of EAE, the immune profiles of leukocytes in the spinal cord as well as
those in the spleen were determined.
Results: When analyzed 16 days after EAE induction, at which time the SF was terminated, the SF group had a
greater number of CD4+ T cells and a higher percent of CD4+ cells among all leukocytes in the spinal cord than the
resting EAE group. When allowed to recover to 28 days after EAE induction, the SF mice had lower EAE scores than
the resting EAE group. EAE induced splenomegaly and an increase of Gr1+CD11b+ myeloid-derived suppressor cells
in the splenocytes. However, SF treatment had no additional effect on either peripheral splenocytes or granulocytes
that reached the spinal cord.
Conclusion: The SF maneuver facilitated the migration of encephalopathic lymphocytes into the spinal cord.
Paradoxically, these mice had a better EAE score after cessation of SF compared with mice without SF.
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Sleep is a restorative process for the biological system
[1-3]. Disruption of sleep is generally thought to have
adverse effects on the progression of autoimmune dis-
eases, as seen in systemic lupus erythematosus [4] and
rheumatoid arthritis [5]. In human subjects with multiple
sclerosis (MS), treatment of sleep disorders improves
symptoms of fatigue [6]. Experimental autoimmune en-
cephalomyelitis (EAE) is an autoimmune disease targeting
myelin components in the central nervous system (CNS).
It serves as a useful autoimmune model for MS. While* Correspondence: biopotentials@outlook.com
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ance, mice with EAE show mainly sleep fragmentation
(SF) and reduced sleep efficiency. This is seen throughout
the course of the symptomatic phase in the Friend Virus
B-Type (FVB) strain of female mice, with the extent of
sleep disruption correlating with EAE symptoms [7]. This
has led to the hypothesis that sleep disruption worsens
EAE. We tested this by a chronic experimental SF
maneuver applied during the light span when mice
typically would be asleep. This SF protocol has been
shown to successfully increase sleep state transition and
reduce non-rapid eye movement (NREM) sleep across the
days of manipulation, with fast recovery after cessation of
SF [8].is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
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ing hyperactive helper T cell (Th)-1 and Th-17 responses
with CD4+ cells targeting the myelin components in the
spinal cord and brain. Th1 cytokines, including interferon
(IFN)-γ and tumor necrosis factor (TNF)-α, are also ele-
vated in EAE [9]. Even in mice without autoimmune dis-
ease, there are dynamic interactions between leukocytes
and cytokines and the blood–brain and blood-spinal cord
barriers (BBB). For example, fibroblast growth factor-19
crosses the BBB by a non-saturable transport system [10],
whereas TNF and leukemia inhibitory factor show regula-
tory changes in their saturable transport across the BBB
[11-14]. Most recently, we showed that chronic sleep re-
striction induces multifaceted changes in BBB function,
including an increase of paracellular permeability to small
tracers, reduction of glucose uptake, and inflammation of
the cerebral endothelia [15].
Thus, we postulated that sleep manipulation changes
T cell activity and modifies the course of EAE. In healthy
men, Th1 activity is highest in early nocturnal sleep, with
increased production of IFN-γ and interleukin (IL)-4,
whereas the Th2 response occurs during late sleep fol-
lowing release of prolactin and growth hormone. The
production of TNFα by CD8+ T cells is decreased after
sleep. The results indicate that there are distinct circa-
dian rhythms of T cell activity with regard to Th1 and
Th2 balance [16]. Therefore, we analyzed both CD4 and
CD8 T cell populations in the spleen and spinal cord to
determine the immunopathology of EAE mice in response
to SF. In mice with an astrocytic leptin-receptor mutation
and worsened EAE, we have shown a reduction in the per-
cent of Gr1+CD11b+ subtype of granulocytes infiltrating
the spinal cord [17]. Therefore, this population of leuko-
cytes was also analyzed to test the hypothesis that this
leukocyte population played a disease-modulating role in
mice after SF.
Materials and methods
Animals and EAE induction
C57BL/6 J mice were obtained from Jackson Laboratory
(Bar Harbor, ME, USA) and housed in the animal care
facility for 1–2 weeks before induction of EAE at age 8–
10 weeks, following a protocol approved by the PBRC
Institutional Animal Care and Use Committee. Females
were used because they are more susceptible to EAE. All
mice were housed in groups of four in round acrylic
sleep recording cages (Pinnacle Technology, Lawrence,
KS, USA) and adapted for 3 days before initiation of SF
or control experiments.
EAE induction was similar to that reported recently
[7,17,18], with minor modifications. In brief, 80 or 100 μg
of myelin oligodendrocyte glycoprotein (MOG) fragment
35–55 (MOG35–55) was fully emulsified in 100 μl of
complete Freund’s adjuvant (CFA) containing 500 μg ofheat-killed Mycobacterium tuberculosis H37RA (DIFCO
Laboratories, Detroit, MI, USA). The mixture was deliv-
ered subcutaneously, divided among three flank areas.
Pertussis toxin (Sigma, St. Louis, MO, USA) was injected
intraperitoneally immediately after induction and then
again 48 h later. The time of induction was considered
EAE day 0. Symptoms were monitored daily at about
noon (zeitgeber time, ZT6) by use of a standard EAE scor-
ing system [11,19,20], with 0 being symptom-free and 5
being the worst (moribund or dead).
Experimental SF maneuver
Three groups of mice were used (n = 8 /group): (1) EAE
mice with SF during the light phase from day −10 to
day +16 in relation to EAE induction (on day 0). SF was
applied between zeitgeber time (ZT) 0–12; (2) resting
EAE mice without SF intervention; (3) naïve controls
with neither EAE nor SF. The dose of MOG35–55 was
100 μg/mouse. The mice were sacrificed on day 16 after
EAE induction, immediately after cessation of SF.
In a second study to determine the progression of
EAE symptoms, 2 groups of mice were studied (n = 8/
group): SF EAE mice and resting EAE mice, as for first
group above. In this case, EAE scores and body weight
were monitored from day 0 till day 28 after EAE induc-
tion. The dose of MOG35–55 was reduced to 80 μg/mouse:
by reducing the dose of the heptagen, we aimed to achieve
a lower EAE score in this batch of mice. This would en-
sure that mice were not too incapacitated to have the SF
procedure and that they could be monitored through the
course of EAE to 28 days. This would increase the prob-
ability of identifying the effect of SF, as we hypothesized
that SF worsens EAE.
The SF maneuver agitated the mice every 2 min by use
of random bar rotation driven by a computer program.
The mice were group-housed in round cages (3 – 4 mice/
cage). At the bottom of the cage is a metal bar slightly
shorter than the inner diameter of the round cage and
positioned above the corncob bedding. A computer-
controlled SF schedule repeats on a 120 s cycle (30 s on,
90 s off) during the light span (6 am to 6 pm, ZT0-12),
with an intermediate bar rotation speed (scale of 5 out
of 10). The direction of bar rotation is randomly reversed
every 10–40 sec. The choice of 30 events/h of SF used
was based on clinical evidence from severe sleep apnea,
and shown to be effective in compromising sleep architec-
ture in mouse and rat [21,22]. The effective reduction of
NREM sleep and increased sleep fragmentation with this
SF maneuver has been validated by sleep recording and
sleep architectural analysis, as we have reported recently
[8]. In brief, SF increases Wake time by about 25% in the
12-h light span, reduces % NREM by about 20%, but
decreases REM sleep only during the first night. The
changes are consistent across the 10 d of SF despite the










































































Figure 1 Effect of sleep fragmentation (SF) on EAE scores and disease progression. SF was applied from 10 days before EAE induction until
16 days after induction. (A) Three groups of mice (n = 8 /group) were studied: without induction of EAE (naïve), induction of EAE with 100 μg
/mouse of MOG35–55 without SF (resting) and with SF (ZT 0–12 SF). By the end of the study on day 16, there was no difference in EAE score
between the resting EAE group and the SF EAE group (ZT0-12 SF). (B) Two groups of mice (n = 8/group) with EAE induction with 80 μg/mouse
of MOG35–55 were monitored until day 28. In the SF EAE group (ZT 0–12 SF), the EAE scores were lower in the recovery phase (Day 16–28) than
resting EAE, shown both by the daily progression and the cumulative score (inset). *: p < 0.05.
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control C57 mice have about 39% Wake, 56% NREM,
and 5% REM. The SF maneuver also increases sleep
state transitions: NREM bouts increase 2–3 fold, as do
Wake bouts. In the dark span, the percent of Wake,
NREM, and REM show no significant changes, and
there is no increase of sleep fragmentation. This indi-
cates a lack of circadian shift resulting from the SF
maneuver. Recovery from SF is rapid, as sleep architec-
ture returns to baseline within 24 h after the cessation
of SF [8].Flow cytometry
Three groups of mice were studied (n = 8 /group): naïve,
resting EAE, and SF EAE where SF was applied 10 days
before EAE induction and terminated on day 16 of EAE,
immediately before sacrifice of the mice in the after-
noon (ZT6-9). To isolate leukocytes from the spinal
cord and spleen following an established protocol [23],
mice were anesthetized by intraperitoneal injection of
urethane (30 mg/kg). They were perfused intracardially
with phosphate-buffered saline (PBS) to remove leuko-
cytes in the spinal cord vasculature. The spinal cord
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serum. Leukocytes were recovered at the 30:70% Percoll
interface after gradient centrifugation as described pre-
viously [17]. To obtain splenocytes, spleens were rup-
tured, homogenized, filtered through a 40 μm nylon
mesh, centrifuged, and subjected to red blood cell lysis.
Cells from both tissues were washed with FACS buffer
twice, immunostained, fixed with 2% paraformaldehyde
(PFA), and stored in PBS until flow cytometric analysis.
All antibodies were purchased from BioLegend (San
Diego, CA, USA). For cell surface staining of immune
markers, leukocytes were blocked with anti-mouse CD16/
32 antibody (Clone 93, catalog number 101302), incubated
at 4°C with FITC-conjugated CD4 (Clone GK1.5, catalog
number 100405), PE-conjugated CD8a (Clone 53–6.7,
catalog number 100707), Alexa488-conjugated CD11b
(Clone M1/70, catalog number 101219), APC-conjugated
Gr1 (Clone RB6-8C5, catalog number 108411), or APC-Figure 2 Displays showing the PanLeucogating method and group d
from homogenized spinal cord (A) and spleen (B) in naïve, resting E
SSC: side scatter.conjugated CD45 antibody (Clone 30-F11, catalog number
103112). Control conditions included single staining for
antibodies and non-stained cells to exclude autofluores-
cence. After staining, the cells were fixed with 2% PFA
and stored in PBS for 1–3 days. Cell numbers were esti-
mated by use of a hemocytometer, and the immuno-
fluorescent intensity was analyzed by FACSCalibur (BD
Pharmingen, San Diego, CA, USA). Data were analyzed
with post-collection compensation by FlowJo (Tree Star,
Ashland, OR, USA) software.
The gating strategy was as follows: Cells were first gated
based on side scatter of CD45 immune positive cells,
which differentiates plasma cells, non-lysed erythrocytes,
and their precursors from the CD45+ leukocytes. Blast
cells and other hematogenous cells with low granularity
and low CD45 intensity were located in the left lower
quadrant of the side scatter plot of the CD45+ population,
whereas lymphocytes, which show high CD45 intensityifferences of CD4 and CD8 cells in cells recovered at day 16
AE and SF EAE (ZT 0–12 SF) mice (dose = 100 μg/mouse).






















































Figure 3 Histograms showing both resting EAE and SF EAE (ZT 0–12 SF) mice on day 16 showed an increased infiltration of (A)
leukocytes (CD45+ cells) and (B) the lymphocyte population (low granularity and high CD45 immunofluorescent intensity) in the spinal
cord (n = 8 /group). *: p < 0.05; **: p < 0.01; ***: p < 0.005.
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drant. Granulocytes, including neutrophils of relatively
lower CD45 and eosinophils with higher CD45 immuno-
fluorescence, were gated in the upper right quadrant of
the side scatter plot. Monocytes with high CD45 and
intermediate granularity were separated from the small
number of basophils that had lower granularity. The num-
ber of lymphocytes was then used as the denominator to
determine the percentage of CD4 and CD8 T cells in
double immunostaining. The percentage of CD4 and CD8
cells among all leukocytes was also determined. Although
some macrophages also express CD4 and CD45 and somedendritic cells also express CD8 and CD45 besides lym-
phocytes, these two populations were excluded with gat-
ing for the final analysis. For Gr1 and CD11b double
labeling, there were four clearly defined quadrants repre-
senting Gr1+CD11b+ myeloid-derived suppressor cells,
Gr1−CD11b+ macrophages, monocytes and dendritic cells.
Statistical analysis
Means were expressed with their standard errors. Repeated
measures analysis of variance (ANOVA) was used to deter-
mine the effect of EAE and SF on EAE scores. One-way
ANOVA was used to determine the effect of SF and






























































Figure 4 Histograms showing that SF EAE (ZT 0–12 SF) induced
an increase over resting EAE mice in (A) the total number of
CD4+ T cells and (B) the percent of CD4+ T cells among all
leukocytes infiltrating the spinal cord on Day 16 of EAE (n = 8
/group). *: p < 0.05; **: p < 0.01; ***: p < 0.005.
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lowed by Tukey’s post-hoc test. Student’s t-test (2-tailed)
was used when only two groups were present for com-
parison. Prism GraphPad 5 statistical and graphic pro-
gram (GraphPad, San Diego, CA, USA) was used for
statistics and graphics.
Results
Effect of SF on EAE scores
The incidence rate of EAE was 100% in all EAE groups
at both 100 and 80 μg/mouse doses of MOG35–55. For
both doses, the SF maneuver was initiated 10 days before
EAE induction and terminated 16 days after EAE induc-
tion. In the first experiment with 100 μg of MOG35–55, the
resting EAE mice seemed to show a slightly earlier onset
of symptoms at day 10 compared with the SF mice on the
same day. However, this was not statistically significant
and there was no difference between the EAE groups at
day 16 (Figure 1A). Since we hypothesized that SF will
worsen EAE, SF was expected to increase the EAE score
from the control (non-SF) group to a higher score (greater
severity). However, we considered that any effect of SF
might have been masked by the severe EAE in mice re-
ceiving the higher dose (a score of about 3.5 in compari-
son with a score of 2 at the lower dose on day 16). In this
case, using mice that achieved a lower basal score would
be more likely to identify a potential effect.
To further test the hypothesis that SF worsens EAE, the
second study used a lower dose of MOG35–55 (80 μg/
mouse). In the resting EAE group, EAE symptoms
emerged on day 12, gradually increased in severity, and
reached a peak on day 21. These mice were allowed to re-
cover until day 28 at which time they were euthanized
along with resting EAE and naïve mice. At the lower dose
of MOG35–55 (80 μg/mouse), there was a significant effect
on EAE score of SF [F (1,348) = 40.6, p < 0.001] and of
days after EAE [F (28,348) = 72.1, p < 0.001], and their
interaction was also significant (p < 0.001). The average
score from Day 16 to Day 28, derived from analysis of the
area under curve, was significantly reduced in the mice
with previous SF (p < 0.05) (Figure 1B, inset). Overall, the
cessation of SF with 12 days of recovery stabilized the
EAE score with improvement over the resting (non SF)
EAE group (Figure 1B).
SF increased leukocyte infiltration into the spinal cord
compared with the splenocyte immune profile
To test the hypothesis that SF is associated with an in-
crease in the infiltration of leukocytes, particularly lym-
phocytes, across the blood-spinal cord barrier, leukocytes
from the spinal cord and splenocytes from the spleen were
subjected to flow cytometry after extraction on day 16
after induction in the three groups of mice: naïve, resting
EAE, and SF EAE (100 μg/mouse). Populations ofleukocytes from spinal cord (Figure 2A) and spleen
(Figure 2B) were gated based on CD45 positivity on side
scatter plots as described in Methods above, and further
differentiated into CD4 and CD8 (+) populations after
dual immunostaining. One-way ANOVA showed that
EAE increased the infiltration of CD45+ leukocytes in both
EAE groups [F (2, 15) = 20.05, p < 0.001] (Figure 3A)
although the results did not show a significant difference
when the SF group was compared with the resting EAE
mice. This negative finding was important and contrasts
with an increase of the infiltrating CD4 T cells shown
below. For the lymphocyte subpopulation, EAE resulted in
a greater increase in infiltration compared with the naïve
mice [F (2, 16) = 15.9, p < 0.001] (Figure 3B). SF EAE had
more infiltrated lymphocytes than resting EAE (p < 0.05).
The total number of CD4+ T cells in the spinal cord
was higher in the SF EAE mice than the resting EAE
group [F (2, 14) = 20.46, p < 0.001) (Figure 4A). The per-
cent of CD4+ cells among all infiltrated leukocytes was
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Figure 5 Effects of EAE on the spleen in mice at day 16 after induction: SF had no additional effect besides that of EAE to modulate
peripheral immune cell proliferation (n = 8 /group). (A) EAE induced significant splenomegaly. (B) Gating of Gr1 and CD11b (+) populations
with double labeling. (C) The total number of Gr1+CD11b+ cells was increased by EAE but SF had no additional effect. *: p < 0.05; **: p < 0.01.
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CD8+ cells or Gr1+CD11b+ cells in the post-hoc Tukey’s
test, despite a significant overall effect of EAE shown by
ANOVA (data not shown).SF did not increase Gr1+CD11b+ cells among splenocytes
That EAE activates the immune system was shown by
increased splenic weight in EAE mice [F (2, 15) = 9.01,
p < 0.01] despite all showing significant body weight loss
(Figure 5A). Coinciding with the reduction of the number as
well as the percent of CD4+ and CD8+ T cells, the Gr1
+CD11b+ myeloid-derived suppressor cells were increased
in the spleen of EAE mice [F(2, 16) = 11.34, p < 0.001].
The gating of the cells and representative flow cytometric
patterns are shown in figure 5B. SF had no additional effects
on the Gr1+CD11b+ splenocytes besides EAE (Figure 5C).Discussion
Leukocyte infiltration into the CNS involves complex
interactions between leukocyte antigens and the bar-
riers of the CNS. Immune cells cross the BBB by a reg-
ulated process termed diapedesis. Results from this
study showed that SF increased the percentage of leu-
kocytes, particularly lymphocytes, infiltrating the spinal
cord on day 16 of EAE, a time when the immune reac-
tion and interactions among infiltrated cells and CNS
residential cells were both active. In comparison with
the resting EAE group, SF was associated with more
CD4+ T cell infiltration into the spinal cord. There was
also a higher percent of CD4+ T cells among all infil-
trated leukocytes. This contrasts with a lack of add-
itional effect of SF on EAE-induced splenomegaly and
increased granulocytes in the spleen or spinal cord. Overall,
the results suggest that an exaggerated CNS autoimmune re-
sponse is typically associated with worsening of EAE [17,18].
Sleep-wake activity also modulates regulatory T (Treg)
cells in healthy men; natural Treg cell counts and their
suppressive activity appear to be highest during the night
and lowest during the day. Sleep deprivation not only
abrogates the rhythm of CD4+CD25+ Tregs but also re-
duces the proliferation of CD4+CD25− naïve T cells [24].
In EAE mice most of the NREM sleep loss and sleep
fragmentation occurs in the light span (when the mice
typically would be asleep), and there are dynamic changes
at different stages of EAE [7]. This provided a basis for
the application of SF in the light phase. Although we
did not detect a circadian shift of sleep-wake cycle in
naïve SF mice [8], the presence of recovery sleep in the
dark phase and a circadian shift of sleep-wake activity
cannot be ruled out in the SF EAE mice. These factors
may have contributed to the circadian patterns of en-
cephalopathic T cells and cytokines, as well as their
neuroendocrine regulation.Even in the absence of EAE, sleep disturbance with in-
creased fragmentation and loss of about 20% of daily
sleep for 6 days is sufficient to affect BBB function. There
is increased paracellular permeability to sodium fluores-
cein, and higher uptake of biotin in certain regions that
might involve both increased transport and increased BBB
permeability, reduction of glucose uptake across the BBB,
decreased vascular reactivity as well as regulatory changes
of a series of transport-related proteins, and increased
BBB inflammation [15]. As the result of immune cell infil-
tration and proliferation, the CNS undergoes inflamma-
tion, reactive gliosis, demyelination, and neuronal damage,
producing distinct phases of EAE. The course of pro-
gression and recovery can be collectively reflected by
behavioral scores, immune profiling, BBB damage, and
morphological and biochemical changes of the CNS.
These aspects can be regulated by sleep and its disor-
ders as a result of alterations of hormones and neuro-
transmitters, and their circadian rhythms.
Conclusion
In summary, we showed that SF increased the percent-
age of lymphocytes infiltrating the spinal cord on day 16
of EAE, particularly the number and percent of CD4+ T
cells among all leukocytes. Overall, the results suggest a
modulatory effect of SF on EAE progression. A better
understanding of the effects of SF on EAE and the un-
derlying mechanisms is essential, as this may lead to new
strategies to maximize sleep treatment for optimal neuro-
logical function in patients with MS.
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